Skip to main content
Clinical Trials/NCT06291662
NCT06291662
Recruiting
Not Applicable

Evaluation of Performance Characteristics and Applicability in Oncology of Devices Customized Medical Devices Made by 3D Printing

Kathleen McGreevy3 sites in 1 country12 target enrollmentJanuary 1, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Sarcoma
Sponsor
Kathleen McGreevy
Enrollment
12
Locations
3
Primary Endpoint
Device feasibility
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

Technologies 3D are demonstrating enormous potential for innovation in the field of surgery,introducing the concept of "treatment customization" (from planning surgery to implant design and manufacturing) on the patient's anatomy, simply by taking advantage of the patient's own common diagnostic images and the flexibility of 3D printing. In fact, this new construction technology allows the construction of the complex anatomical geometries with economy, simplicity and on scales of production unattainable by other traditional technologies. This new construction technology allows, in fact, the construction of complex anatomical geometries with economy, simplicity and on scales of production unattainable by other traditional technologies.

Registry
clinicaltrials.gov
Start Date
January 1, 2021
End Date
June 30, 2025
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Kathleen McGreevy
Responsible Party
Sponsor Investigator
Principal Investigator

Kathleen McGreevy

Chief Operating Officer, Meyer Children's Research Institute

Meyer Children's Hospital IRCCS

Eligibility Criteria

Inclusion Criteria

  • Primary tumor of the pelvic bone Primary meta-diaphysial tumor of the long bones; squamous cell carcinoma of the oral cavity in the upper and/or lower jaw. over 10 years of age
  • Primary sarcoma of bone and soft parts involving the scapula, the pelvis and upper and lower limbs; brain tumor aged 7-18 years
  • Intracranial oncologic pathology with bone involvement and lesions of the skull theca primary or secondary aged 18-70years
  • signed informed consent form

Exclusion Criteria

  • inoperability;
  • presence of pathological fractures.

Outcomes

Primary Outcomes

Device feasibility

Time Frame: through study completion, an average of 1 year

Proportion of failed surgeries due to a positive or contaminated finding of the margin of bone resection on final histological examination. verified by comparing the expected outcome (i.e., planning output) and the actual outcome (on the postoperative CT scan).

3D model feasibility for pre-surgical making decisions

Time Frame: through study completion, an average of 1 year

Number of cases in which the time interval between prescription and delivery of the device exceeds 20 days

Surgical time

Time Frame: through study completion, an average of 1 year

Number of procedures in which the surgical outcome can be considered optimal (taking planning as a reference) by comparing CT images and evaluating the margins at final histologic analysis.

Study Sites (3)

Loading locations...

Similar Trials